Skip to main content
Caplight Logo









AN2 Therapeutics

AN2 Therapeutics

Public
Menlo Park, CaliforniaHealthcarehttps://www.an2therapeutics.com

AN2 Therapeutics is now publicly traded

The data on this page reflects AN2 Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Follow-on Offering

Mar 25, 2026

Total Funding Raised

$40M

Company Overview

AN2 Therapeutics (NAS: ANTX) is a biopharmaceutical company focused on developing innovative treatments for rare and serious infectious diseases with significant unmet medical needs.

Sector

Healthcare

AI Layer

Non-AI

Keywords

boron chemistry drug discovery platformsmall molecule therapeutics for infectious diseasesoral therapeutic for non-tuberculous mycobacterial (NTM) lung diseaseleucyl-tRNA synthetase inhibitortherapeutics for rare infectious diseasestherapeutics for M. abscessus lung diseaseChagas disease therapeutic developmentmelioidosis treatment developmentdrug development for difficult-to-treat infectionsdrug commercialization licensing modelglobal health infectious disease researchpreclinical oncology program

AN2 Therapeutics Comparables

Compare AN2 Therapeutics with similar companies based on industry and business-model similarity.

AN2 Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

AN2 Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Follow-on OfferingMar 25, 2026
View all Funding Rounds

AN2 Therapeutics Investors

Notable investors and investment history

AN2 Therapeutics investors
InvestorRounds
Coastlands Capital LPFollow-on Offering
Commodore CapitalFollow-on Offering
Vivo CapitalFollow-on Offering
View all Investors

AN2 Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AN2 Therapeutics Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersMenlo Park, California
Employee Range35
Year Founded2019
Last FundingMar 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?